ClinicalTrials.Veeva

Menu

Communicating Health Options to Inform Care and Empower Strategic Care Planning (CHOICES): A Multi-layer Randomized Case Vignette Study.

M.D. Anderson Cancer Center logo

M.D. Anderson Cancer Center

Status

Enrolling

Conditions

Health Options
Strategic Care Planning

Treatments

Behavioral: Randomized Case Vignette Study

Study type

Observational

Funder types

Other

Identifiers

NCT06722846
2024-0531
NCI-2024-10042 (Other Identifier)

Details and patient eligibility

About

To learn more about how the delivery of medical information affects therapy choices for participants with advanced forms of cancer.

Full description

Primary Objectives • To examine how provision of medical information (risks, benefits, time toxicity, prognosis, oncologists' recommendation, and costs) affects preference for palliative systemic therapy in participants with advanced cancer.

Secondary Objective

• To examine how different options of medical information (risks/benefits, time toxicity, prognosis, oncologists' recommendation, and costs) affect preference for palliative systemic therapy in participants with advanced cancer.

Exploratory Objective

  • To examine how the order of presentation of medical information affects preference for palliative systemic therapy in participants with advanced cancer.
  • To examine the association between intrinsic participants characteristics (such as participants demographics, symptoms, anxiety, depression, illness understanding, acceptance, coping strategies, religious coping, hope, decision making style, trust in oncologist, financial distress) and preference for palliative systemic therapy in participants with advanced cancer.

Enrollment

400 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

Diagnosis of advanced solid tumor (i.e. metastatic, relapsed, and/or incurable disease) or aggressive lymphoma.

  • Age 18 or greater
  • Seen at MD Anderson Cancer Center Thoracic and Lymphoma Oncology Clinics for a follow-up visit
  • Been treated with at least 2 lines of palliative systemic cancer therapies

Exclusion criteria

  • Diagnosis of cognitive impairment or dementia requiring a surrogate decision maker
  • Non-English speaking

Trial design

400 participants in 1 patient group

Randomized Case Vignette Study
Description:
If participants agree to take part in this study, participants will complete about 16 questionnaires that will have questions about participants quality of life, anxiety, health, and case scenarios that are not real or based on your actual health situation. It should take a bit more than an hour to complete all the questionnaires. If participants find that any of these questions are difficult to read, understand, or otherwise complete; or if they cause distress, participants may ask the study team for clarification, skip the question, or even stop the study at any time. Additionally, information will be collected from participants medical record about participants health and treatment, as well as participants demographic information (age, race, sex, and so on). Investigators may also ask participants for additional demographic information not found in your medical record.
Treatment:
Behavioral: Randomized Case Vignette Study

Trial documents
1

Trial contacts and locations

1

Loading...

Central trial contact

David Hui, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems